SEC Tracker
Get the app

Synergy CHC SNYRQ

Synergy CHC FY 2016: revenue $34.8M

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Synergy CHC reported for the year ended Dec 31, 2016, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$34.8MNo year-earlier figure tagged10-K income statement, on EDGAR
  2. Net income−$796KNo year-earlier figure tagged10-K income statement, on EDGAR
  3. Cash and cash equivalents$2.5MNo year-earlier figure tagged10-K balance sheet, on EDGAR
  4. Cash from operations$6.0MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Synergy CHC files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2833 and related industry codes: the same peer list as the financial tables.

  1. Cellectar Biosciences CLRB public float $13M, Jun 30, 2025
  2. Earth Science Tech ETST public float $14M, Mar 31, 2026
  3. GeoVax Labs GOVX public float $14M, Jun 30, 2025
  4. Edesa Biotech EDSA public float $14M, Mar 31, 2025, over 18 months old
  5. Cypherpunk Technologies CYPH public float $12M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.